AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 92.23 USD 0.61% Market Closed
Market Cap: $286B

Operating Margin

32.9%
Current
Improving
by 5.4%
vs 3-y average of 27.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
32.9%
=
Operating Income
$14.2B
/
Revenue
$58.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
32.9%
=
Operating Income
$14.2B
/
Revenue
$58.1B

Peer Comparison

Country Company Market Cap Operating
Margin
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.9B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.5B EUR
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
110.6B USD
Loading...
UK
GSK plc
XETRA:GS71
83.5B EUR
Loading...
DE
Bayer AG
XETRA:BAYN
43.8B EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...

Market Distribution

Higher than 99% of companies in United Kingdom
Percentile
99th
Based on 3 579 companies
99th percentile
32.9%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

AstraZeneca PLC
Glance View

AstraZeneca PLC stands as a formidable entity in the global pharmaceutical landscape, adeptly navigating the intricate dance of innovation and commerce. Emerging from a merger between Sweden's Astra AB and the UK's Zeneca Group in 1999, the company has carved a niche through its relentless pursuit of cutting-edge medical solutions. Central to its operations is a sophisticated ecosystem of research and development, where thousands of scientists tirelessly explore the expansive frontier of biotechnology. The lifeblood of AstraZeneca's growth is its robust pipeline, where potential life-saving medicines traverse an arduous journey from laboratory benches to clinical trials, and eventually, regulatory approval. This rigorous process underscores its commitment to addressing complex diseases in areas such as oncology, cardiovascular, and respiratory health – domains marked by high unmet medical needs and significant market demand. The commercial prowess of AstraZeneca is equally vital to its success narrative. With a global reach spanning over 100 countries, the company leverages its advanced production facilities and strategic partnerships to deliver its pharmaceutical breakthroughs to those in need. Revenue generation is predominantly through the sale of prescription drugs, with blockbuster medications serving as pivotal financial pillars. These products, once approved, are strategically marketed to healthcare providers, ensuring they gain traction in various markets. AstraZeneca's approach is finely tuned to balance the scale of mass production with the nuance of catering to specific regional demands, maintaining a competitive edge in a crowded pharmaceutical landscape. Through these intricacies of innovation, production, and strategic market positioning, AstraZeneca not only generates substantial revenues but also reinforces its mission to improve patient health outcomes worldwide.

AZN Intrinsic Value
103.38 USD
Undervaluation 11%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
32.9%
=
Operating Income
$14.2B
/
Revenue
$58.1B
What is AstraZeneca PLC's current Operating Margin?

The current Operating Margin for AstraZeneca PLC is 32.9%, which is above its 3-year median of 27.5%.

How has Operating Margin changed over time?

Over the last 3 years, AstraZeneca PLC’s Operating Margin has increased from 18.9% to 32.9%. During this period, it reached a low of 18.9% on Aug 30, 2022 and a high of 33.5% on Jun 30, 2025.

Back to Top